This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Its Use in Localized, Recurrent, or Refractory Cases

BRIAN RUSSELL, M.D.

AMA Arch Derm Syphilol. 1951;64(6):676-683.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THERE is general agreement today that the treatment of lupus vulgaris by massive dosage with vitamin D₂, as first described by Charpy (1943 and 1946)¹ and by Dowling and Prosser Thomas (1945 and 1946),² leads to marked clinical improvement in most cases and apparent cure in some. Ruiter and Groen (1950)³ reported clinical cure in 32% of 100 patients and stated that the clinical cures reported by other authors vary from 24 to 60%. Ingram and Anning (1948),⁴ on the other hand, reported cure in about 2.5% of 158 patients treated, whereas Gauvain (1948)⁵ reported clinical cure in 8 of 11 patients treated (72%). These widely differing percentage results may depend on variable criteria of cure employed by different authors and on varying dosages and techniques.

Nevertheless, Ruiter and Groen reported that 9% of their patients were refractory to this treatment and another . . . [Full Text PDF of this Article]

Author Affiliations
LONDON, ENGLAND

From St. Bartholomew's Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter     What's this?